Characteristics associated with adequate folic acid supplementation in a multicultural urban setting

Canadian Journal of Hospital Pharmacy

Volumn 59, Issue 1, 2006, Pages 22-28

  Ferreira, Ema ^a   Atkinson, Suzanne ^a   Gauthier, Lise ^b   Bussières, Jean François ^a   Rey, Evelyne ^a   Dumont, Marc ^c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Laviguer and Gauthier Pharmacy in Acton Vale   (Canada)

^c Laviguer and Gauthier Pharmacy in Acton Vale ^*

Author keywords

Folic acid; Neutral tube defects; Pregnancy

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

ARTICLE; BIRTHPLACE; CANADA; DEMOGRAPHY; EDUCATION; FEMALE; HEALTH EDUCATION; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; INCOME; MARRIAGE; MATERNAL DISEASE; MATERNITY WARD; NEURAL TUBE DEFECT; OUTPATIENT DEPARTMENT; PARITY; PREGNANCY; PRENATAL CARE; URBAN AREA; VITAMIN SUPPLEMENTATION;

EID: 34249656830     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Les anomalies congénitales au Canada - rapport sur la santé périnatale 2002. Ottawa (ON): Health Canada; 2002. p. 7-13.
2. MacDonald SD, Ferguson S, Tam L, Lougheed J, Walker MC. The prevention of congenital anomalies with periconceptional folic acid supplementation. J Obstet Gynaecol Can 2003;25:115-21.
3. ACOG Committee on Practice Bulletins. Neural tube defects. ACOG Pract Bull 2003;44:203-13.
4. Wilson RD. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Soc Obstet Gynaecol 2003;25:959-5.
5. De Wals P, Rusen ID, Lee NS, Morin P, Niyonsenga T. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol 2003;67:919-23.
6. Geisel J. Folic acid and neural tube defects in pregnancy: a review. J Perinat Neonatal Nurs 2003; 17:268-79.
7. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Council Vitamin Study. Lancet 1991;338:131-7.
8. Czeizel AE, Dudas I. Prevention of first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
9. Berry RJ, Li Z, Erickson D. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999;341:1485-90.
10. Mulinare J, Cordero J, Erickson J, Berry R. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-5.
11. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-9.
12. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural-tube defects. JAMA 1989;262:2847-52.
13. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Fielding DW, et al. Further experience of vitamin supplementation for prevention of neural tube defects recurrences. Lancet 1983;1:1027-31.
14. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 1990;10:149-52.
15. Czeizel AE. Primary prevention of neural-tube defects and some other congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy. Paediatr Drugs 2000;2:437-49.
16. Kallen BAJ, Olausson PO. Use of folic acid and delivery outcome: a prospective registry study. Reprod Toxicol 2002;16:327-32.
17. Morin P, De Wals P, Noiseux M, Niyonsenga T, St-Cyr-Tribble D, Tremblay C. Pregnancy planning and folic acid supplement use: results from a survey in Quebec. Prev Med 2002;35:143-9.
18. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001;358:2069-73.
19. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
20. Ray JG, Meier C, Vermuelen MJ, Boss S, Wyatt PR, Cole DEC. Association of neural tube defects and folic acid fortification in Canada. Lancet 2002;360:2047-8.
21. Braekke K, Staff C. Periconceptional use of folic acid supplements in Oslo. Acta Obstet Gynecol Scand 2003;82:620-7.
22. Tam L, Smith G, Salienics ME, Windrim R, Walker MC. Periconceptional folic acid usage: a multiethnic survey [abstract]. Annual clinical meeting of Society of Obstetricians and Gynaecologists of Canada; 2000 Jun 20; Montréal, Quebec.
23. Egen V, Hasford J. Prevention of neural tube defects: effect of an intervention aimed at implementing the official recommendations. Soz Praventivmed 2003;48:24-32.
24. Wald NJ. Folic acid and the prevention of neural-tube defects. N Engl J Med 2004;350:101-3.